Home > Products > API > Pioglitazone hydrochloride
Pioglitazone hydrochloride
  • Pioglitazone hydrochloridePioglitazone hydrochloride

Pioglitazone hydrochloride

Product Name:Pioglitazone hydrochloride
Formulae hypotheticae: C19H21ClN2O3S
M. Pondus; 392.9
CAS Subcriptio Number; 112529-15-4

Model:CAS NO:112529-15-4

Mitte Inquisitionem

depictio producti

Pioglitazone hydrochloride

Product nomen:Pioglitazona hydrochloridis 112529-15-4
CAS No:112529-15-4
Specification: in domo

Nomen Pioglitazone hydrochloride
Synonyma 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzylidine]-2,4-thiazolidinedionehydrochloride;AD-4833;pioglitazonehydrochioride;Pioditazonehydrochloride;PIODLITAZONEHYDROCHLORIC; -(5-Chemic albookETHYL-PYRIDIN-2-YL)-ETHOXY]-BENZYL}-THIAZOLIDINE-2,4-DIONEHCL;5-{4-[2-(5-Ethyl-pyridin-2-yl )-ethoxy]-benzyl}-;5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dionehydrochloride
copyRight
M. Structure CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C19H21ClN2O3S
M. Pondus 392.9
CAS Subcriptio Number 112529-15-4


Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Pioglitazona hydrochloridi, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept